Next Article in Journal
Critical Steps and Common Mistakes during Temporal Bone Dissection: A Survey among Residents and a Step-by-Step Guide Analysis
Previous Article in Journal
Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 14
Issue 4
10.3390/jpm14040348
Review Report
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

Outcomes of Endoscopic Endonasal Dacryocystorhinostomy in Glaucoma Patients

J. Pers. Med. 2024, 14(4), 348; https://doi.org/10.3390/jpm14040348
by Gian Marco Pace 1,2, Francesco Giombi 1,2,*, Giovanna Muci 1, Gianmarco Giunta 1, Francesca Pirola 2, Egidio Serra 1,2, Jessica Zuppardo 1,2, Fabio Ferreli 1,2, Paolo Vinciguerra 1,3, Giuseppe Mercante 1,2, Alessandra Di Maria 1,3, Giuseppe Spriano 1,2 and Luca Malvezzi 1,2,4
Reviewer 1:
Nicoleta Anton
Reviewer 2: Anonymous
J. Pers. Med. 2024, 14(4), 348; https://doi.org/10.3390/jpm14040348
Submission received: 6 March 2024 / Revised: 22 March 2024 / Accepted: 25 March 2024 / Published: 27 March 2024
(This article belongs to the Section Personalized Therapy and Drug Delivery)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

It is a interesting study.

I evaluated the article entitled Outcomes of endoscopic endonasal dacryocystorhinostomy in 2

glaucoma patients and I have the following comments:

Introduction. Well-documented, but it would be interesting to mention more studies related to glaucoma vs DCRS relationship

Material and method.

Lines 99. Perhaps to inclusion criteria if it can be specified how many antiglaucoma drugs he puts and for how long.

Which was coded vis-à-vis antiglaucoma medication after surgery.

Results: no reference to glaucoma or antiglaucoma medication. The recurrence of dacryocystitis is the sea detul.

Conclusions. It can be improved. It should reflect the results

Kind regards

 

 

 

Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

While being a retrospective study with all the inherent risks for biases, I think it addresses an interesting point, which warrants its publishing.

As the authors state, it appears to be the largest case series of EE-DCR in patients that have previously been using topical antiglaucoma medication. The study proves that EE-DCR remains an effective surgery in this particular type of patients. 

I only have a few comments:

line 44 - "Secondary nasolacrimal duct obstruction (SANDO) is defined whenever a specific inflammatory event is responsible" - one can argue that neoplasia or trauma may not include necessarily an inflammatory event

It would be interesting to know how long was the antiglaucoma medication used before the surgery (however, being a retrospective study, this information may not be available).

line 153  - please explain the meaning of the term "eye dubbing"

Tables 2 and 3 - I do not support reporting the success by the operated side (left or right). It does not bring additional useful information.

lines 196-197 - "lacrimal gland inflammation' - do you mean "lacrimal sac inflammation' ?

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop